Researchers have created a new platform with the potential to extract tiny circulating biomarkers of disease from patient blood. This simple, fast and convenient technique could help realize liquid biopsy diagnostics -- a less invasive procedure than the current gold standard: tumor biopsies.
Researchers have created a new platform with the potential to extract tiny circulating biomarkers of disease from patient blood. This simple, fast and convenient technique could help realize liquid biopsy diagnostics -- a less invasive procedure than the current gold standard: tumor biopsies.
Share this Article
Recommended